Book an Appointment
Innovative and regenerative medicine methods are increasingly coming to the forefront in the treatment of eye diseases. Specifically, stem cell therapy and PRP (Platelet Rich Plasma) applications are among the biotechnological solutions developed to protect eye health and enhance visual function. In addition to traditional treatments, these advanced approaches—aimed at cell renewal and tissue repair—offer promising results in many ophthalmic diseases such as retinal degeneration, corneal damage, optic nerve damage, and dry eye. These treatments, performed with biological materials obtained from the patient’s own body, have a major advantage in terms of tissue compatibility and minimize the risk of immunological response. While stem cells initiate regenerative processes in eye tissues to ensure cellular repair, PRP application supports the regeneration of the eye surface and delicate tissues like the retina through the use of blood plasma rich in growth factors. Gain comprehensive information, in light of scientific data, about how stem cell and PRP treatments are used in eye diseases, which diseases they are effective against, and the advantages and possible disadvantages of these therapies.
Table of Contents
What are Stem Cells?
Stem cells are unspecialized cells that play a fundamental role in the body’s renewal and repair processes, possessing the ability to transform into different cell types. These cells are classified into different types, including embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult (mesenchymal) stem cells. Mesenchymal stem cells (MSCs), in particular, are among the most frequently used cells in the field of ophthalmology due to their immune-modulating properties. (Nature Reviews Drug Discovery, 2022)
Stem cell therapy in eye diseases is one of the most promising areas of regenerative medicine applications developed for the purpose of repairing eye tissues that cannot self-renew. Vital eye structures such as the retina, cornea, lens, and optic nerve can be damaged due to aging, genetic diseases, infections, or trauma. Stem cell treatments offer a revolutionary solution for improving patients’ visual function and reducing losses by supporting the regeneration of such damaged tissues. (Stem Cell Reports, 2023)
What is PRP?
PRP (Platelet Rich Plasma) is a biological treatment method considered an important innovation in the field of regenerative medicine that supports cell renewal. PRP is a plasma serum obtained from the patient’s own blood, containing a high concentration of growth factors, cytokines, and healing proteins. Platelets play a critical role in the body’s natural healing process and contain biological agents such as epidermal growth factor (EGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF), which enable the repair of damaged tissues. (Journal of Clinical Ophthalmology, 2023)
PRP treatment is an innovative method in eye healthcare that supports cellular regeneration and offers an alternative in situations where conventional treatments have limited efficacy. It is used as an important supportive treatment in dry eye, corneal damage, retinal diseases, and postoperative recovery processes. Advantages such as PRP being natural and biocompatible, being derived from the patient’s own blood, having a low-risk profile, and promoting cellular repair are making this method increasingly popular.
However, long-term clinical studies on the extent to which PRP offers a permanent solution for eye diseases are ongoing. Currently, research is being conducted on the effectiveness of PRP in the field of ophthalmology in many clinical centers in the USA, Europe, and Japan. If you are wondering whether PRP treatment is suitable for your eye health, you can consult an ophthalmology specialist to evaluate the current treatment options.
The Importance of PRP Application in Eye Health
PRP application is a method that promotes tissue regeneration and cellular repair by accelerating the body’s natural healing mechanisms. In eye diseases, PRP treatment is widely used to alleviate the symptoms of chronic eye conditions and support the regeneration of damaged tissues. It is applied as an alternative or supportive treatment method in many situations such as dry eye, corneal epithelial defects, retinal diseases, and ocular surface disorders. (American Journal of Ophthalmology, 2022)
In eye diseases where adequate results cannot be achieved with traditional treatments, PRP’s anti-inflammatory, immunomodulatory, and tissue-healing properties can slow the progression of the disease and, in some cases, improve visual functions. (The Ocular Surface Journal, 2023)
Areas of Use for PRP in Eye Diseases
PRP treatment is applied in the field of ophthalmology to alleviate the symptoms of various eye diseases and accelerate tissue regeneration:
- Dry Eye (Keratoconjunctivitis Sicca): In patients unresponsive to artificial tear drops, PRP is used as a biological treatment that strengthens the tear film layer and regenerates the corneal epithelium. In dry eye caused by Meibomian Gland Dysfunction (MGD), PRP can stabilize the lipid layer, reducing tear evaporation. In autoimmune-caused dry eyes, such as Sjögren’s syndrome, PRP can reduce inflammation on the ocular surface.
- Corneal Injuries and Wounds: PRP can improve visual functions by accelerating epithelial regeneration to support healing after chemical burns, corneal ulcers, and surgery. It can enable faster healing of the corneal epithelium after refractive surgery. In chronic eye infections, PRP can accelerate healing by supporting the activation of immune cells.
- Retinal Diseases: In retinal diseases like Diabetic Retinopathy and Age-Related Macular Degeneration (AMD), PRP has been shown to slow disease progression by increasing blood circulation and regenerating retinal cells. (International Journal of Retina and Vitreous, 2023). PRP can reduce retinal edema thanks to factors derived from platelets that possess anti-angiogenic properties.
- Post-Laser and Post-Surgical Rehabilitation: After PRK, LASIK, and Cataract surgery, PRP treatment can reduce complication risks by ensuring faster healing of the ocular surface. It can improve postoperative visual quality by lowering the risk of stromal thinning in the cornea.
| Disease Name | Role/Purpose of Stem Cell Therapy |
|---|---|
| Retinitis Pigmentosa | To replace damaged retinal cells or support the health of existing cells. |
| Corneal Dystrophies and Corneal Injuries | To repair and regenerate damaged corneal tissue, restoring corneal transparency. |
| Macular Degeneration (Age-Related Macular Degeneration / AMD) | To regenerate damaged photoreceptor cells or supporting cells in the macula, slowing or halting vision loss. |
| Optic Nerve Damage and Glaucoma | To protect or regenerate damaged optic nerve cells, preventing progressive vision loss due to glaucoma. |
| Retinal Detachment and Other Retinal Diseases | To repair damaged retinal layers, improving retinal function. |
| General Goal | To repair irreversible tissue damage in the eye, preserving and improving visual ability. Potential to halt or reverse the progression of the disease by enabling the regeneration of nerve and epithelial tissues. |
In Which Eye Diseases Is Stem Cell Therapy Applied?
Stem cell therapy is an innovative biotechnological method applied to repair irreversible tissue damage in the eye, preserve, and improve visual ability. Stem cell applications in eye diseases have the potential to halt or reverse the progression of the disease, especially by enabling the regeneration of nerve and epithelial tissues. This treatment has rapidly advanced in recent years, thanks to developments in regenerative medicine and bioengineering, yielding promising results in many ophthalmic diseases.
Stem cell therapy is particularly used in conditions such as retinal diseases, corneal disorders, and optic nerve degenerations. These diseases include:
- Retinitis Pigmentosa
- Corneal Dystrophies and Corneal Injuries
- Macular Degeneration (Age-Related Macular Degeneration / AMD)
- Optic Nerve Damage and Glaucoma
- Retinal Detachment and Other Retinal Diseases
Retinitis Pigmentosa (RP)
Retinitis Pigmentosa (RP) is a genetically based disease that causes progressive retinal degeneration. Characterized by the gradual death of retinal cells, this disease can result in night blindness, peripheral vision loss (tunnel vision), and eventually total blindness.
- Stem cell therapy can help restore the function of retinal tissue by supporting the renewal of retinal pigment epithelial cells.
- Mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) can help preserve photoreceptor cells by increasing blood circulation in the retina.
- In some clinical studies, stem cells injected into the retinal cells have been shown to preserve visual functions to a certain extent and slow the progression of vision loss. (Stem Cell Research & Therapy, 2023)
Corneal Dystrophies and Corneal Injuries
The cornea is the transparent tissue layer located at the front of the eye that refracts light. Corneal dystrophies, traumatic injuries, and infections can compromise the clarity of the cornea, leading to serious vision loss.
- In patients with limbal stem cell deficiency (LSCD), corneal epithelial regeneration can be achieved with stem cell therapy.
- Mesenchymal stem cells applied to the cornea can reduce inflammation, accelerating wound healing and improving visual acuity.
- For patients with chemical burns and those unsuitable for corneal transplant, stem cell therapy offers an important alternative.
Limbal stem cell transplantation can help patients regain their vision by enabling the regeneration of the corneal surface, especially in cases such as burns, autoimmune diseases, and genetic corneal disorders. (The Lancet, 2022)
Macular Degeneration (Age-Related Macular Degeneration / AMD)
Macular degeneration is a retinal disease that primarily develops due to advanced age and causes central vision loss. It is divided into two types: dry and wet.
- In dry type macular degeneration, vision loss occurs due to the death of retinal pigment epithelial cells. Retina cells produced from pluripotent stem cells can be used to repair this damage.
- In wet type macular degeneration, abnormal blood vessels lead to leakage in the retina, accelerating vision loss. Mesenchymal stem cells can prevent bleeding and edema formation by preserving vascular integrity.
Clinical studies conducted in Japan have shown significant improvement in patients’ visual functions using retinal pigment epithelial (RPE) cells produced from stem cells. (Nature Biotechnology, 2023)
Optic Nerve Damage and Glaucoma
The optic nerve is a critical neural pathway that transmits visual information from the eye to the brain, and damage to it can cause permanent vision loss. Glaucoma, optic neuritis, and traumatic optic nerve injuries can lead to permanent loss in the optic nerve.
- Mesenchymal stem cells (MSCs) can be effective in slowing optic nerve degeneration and preserving nerve cells.
- Stem cell-derived growth factors can prevent or reduce vision loss by ensuring the preservation of optic nerve fibers.
- In glaucoma patients, stem cell therapy has been shown to potentially lower intraocular pressure and prevent the loss of optic nerve cells.
Clinical studies have reported that stem cell therapy provided improvement in visual acuity for patients with optic neuropathy. (Journal of Ophthalmology, 2023)
Retinal Detachment and Other Retinal Diseases
Retinal detachment is a serious eye condition that develops when the retina separates from the layers beneath it. This is a medical emergency that can lead to vision loss and blindness.
- Stem cell therapy can reduce cell death after detachment by supporting regeneration in the retina.
- Stem cell-derived growth factors can prevent tissue loss by promoting the survival of retinal cells.
- In patients with retinal degeneration, stem cell therapy can halt the progression of vision loss by supporting cell repair.
Stem cell-based treatments developed for retinal diseases have been observed in clinical trials to improve patients’ contrast sensitivity and visual field. (Ophthalmic Research, 2022)
Stem cell therapy stands out as one of the groundbreaking treatment methods in eye diseases. With many advantages such as reducing the risk of vision loss, repairing nerve tissues, and promoting retinal regeneration, this method will become more widely available in the coming years for preventing blindness and vision loss.
Mechanisms of Action of Stem Cells
Stem cells play a significant role in healing damaged eye tissues thanks to their regenerative properties. Their mechanisms of action include:
- Promoting cell renewal: Ensures the regeneration of damaged cells in eye tissues.
- Reducing inflammation: Slows the progression of eye diseases by reducing inflammation.
- Protecting nerve cells: May help prevent optic nerve damage.
- Increasing blood circulation: Supports vascular health in the retina and cornea.
Mesenchymal Stem Cell Treatment
Mesenchymal stem cells are a particularly promising treatment option for eye diseases. These cells, obtained from bone marrow, adipose tissue, and umbilical cord, support the healing process by adapting to eye tissues.
Mesenchymal stem cell treatment is applied especially in conditions such as retinal diseases, glaucoma, and corneal disorders. Currently, this method continues to yield positive results in clinical studies.
Mesenchymal stem cells (MSCs) are immunomodulatory and regenerative cells widely used in eye diseases. These cells, obtained from bone marrow, adipose tissue, umbilical cord, and amniotic fluid, accelerate the healing process by providing regenerative and anti-inflammatory effects on eye tissues. Mesenchymal stem cells contribute to the treatment of eye diseases through the following ways:
- Promoting tissue regeneration: Supports the reformation of eye tissue by replacing damaged cells.
- Reducing inflammation: Slows the progression of diseases by preventing chronic inflammation in the eye.
- Protecting and repairing nerve cells: Reduces the risk of blindness by preventing the death of optic nerve and retinal cells.
- Improving blood circulation: Supports tissue regeneration by increasing the nourishment of the retina and cornea.
Clinical studies in recent years have shown that mesenchymal stem cell injections slow and, in some cases, reverse vision loss in progressive eye diseases such as glaucoma and retinitis pigmentosa. (Journal of Clinical Investigation, 2023)
Advantages and Disadvantages of Stem Cell Therapy in Eye Diseases
Advantages
- Helps regenerate damaged tissues in the eye.
- Has the potential to improve visual functions in patients at risk of blindness.
- As a natural and biological treatment, the body’s rejection probability is low.
- It is a promising option for patients for whom alternative treatments have not worked.
Disadvantages
- It is still an experimental treatment, and long-term effects are not fully known.
- Expected improvement may not be achieved in some patients.
- Treatment costs can be high.
- Appropriate patient selection for application is important.
PRP Treatment in Eye Patients
PRP is one of the innovative treatments used in ophthalmology in recent years. The application of PRP in dry eye, corneal damage, and retinal diseases is becoming increasingly common.
To understand how PRP is used in eye diseases, it is necessary to examine its advantages and disadvantages in detail.
Advantages and Disadvantages of PRP Treatment in Eye Patients
Advantages
- It is biocompatible because it is obtained from the patient’s own blood.
- It offers a fast recovery process.
- It supports regeneration on the ocular surface.
- It can provide long-lasting relief in chronic conditions such as dry eye.
- It supports eye health by accelerating the healing of the retina and cornea.
Disadvantages
- The treatment may not be permanent and may require regular repetition.
- Obtaining blood from the patient and preparing PRP requires specific expertise.
- Since clinical research is ongoing, definitive results are not yet clear.
- Its effect may be limited for some patients.
Stem cell and PRP treatments in eye diseases are innovative methods that offer promise for improving visual function and slowing the progression of diseases, in addition to traditional treatment methods. These therapies are increasingly used, particularly in chronic conditions such as retinal diseases, glaucoma, corneal disorders, and dry eye.
However, since every patient’s condition is different, it is recommended that you contact an ophthalmologist to find out if stem cell and PRP treatments are suitable for you. If you would like to get more information about stem cell or PRP treatment and evaluate your treatment options, please feel free to contact us.
The text and images on our site are for informational purposes only. They do not substitute for diagnosis and treatment, nor do they carry any legal responsibility.